awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36279476-1A53A709-E87B-4FA5-961B-D347F792BC50
Q36279476-1A53A709-E87B-4FA5-961B-D347F792BC50
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36279476-1A53A709-E87B-4FA5-961B-D347F792BC50
How well does the evidence on pioglitazone back up researchers' claims for a reduction in macrovascular events?
P2860
Q36279476-1A53A709-E87B-4FA5-961B-D347F792BC50
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36279476-1A53A709-E87B-4FA5-961B-D347F792BC50
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
17a1b1ecb06e0a2a7ff31e12cb98d916535cfdff
P2860
Interpreting the results of secondary end points and subgroup analyses in clinical trials: should we lock the crazy aunt in the attic?